Journals / Gaziantep Tıp Dergisi / 2009 / Cilt: 15 - Sayı: 1

Clinical characteristics and treatment modalities of childhood hemangiomas

Çocukluk çağı hemanjiomlarının klinik özellikleri ve tedavi yöntemleri

Pages
71–79
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, management strategies and treatment options are discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hemangiomas are the most common type of congenital anomaly in childhood.
📊
Key Findings & Data:Fortunately, most hemangiomas only grow to small size and do not cause problems.
💡
Conclusion & Impact:In addition, management strategies and treatment options are discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hemangiomas are the most common type of congenital anomaly in childhood. Fortunately, most hemangiomas only grow to small size and do not cause problems. However, there is a small subset of hemangiomas that destroy tissue or endanger the infant's life, either because of tumor's size, location or agressive growth. The pathogenesis of hemangiomas is not well understood, but recent findings suggest a unique vascular phenotype with dysregulated vascular homeostasis. This article reviews new information regarding the pathogenesis of these tumors and highlights the more worrisome presentations, including syndromic hemangiomas, that are likely to be problematic. In addition, management strategies and treatment options are discussed.

Özet

Hemanjiomlar çocukluk çağında en sık görülen konjenital anomalidir. Hemanjiomlar genellikle sorun yaratmaz. Küçük bir bölüm hemanjiom ise doku harabiyetine yol açması, boyutu, yeri ya da agresif büyümesi nedeniyle süt çocuğunda sorun yaratabilir. Hemanjiomların patogenezi çok iyi anlaşılamamıştır, fakat son bulgular vasküler homeostazisteki regülasyon bozukluğu ile vasküler fenotipin ortaya çıktığını desteklemektedir. Bu derlemede bu tümörlerin patogenezi ile ilgili yeni bilgiler, probleme neden olan sendromik hemanjiomları da içeren kaygı verici prezantasyonları sunulmuştur. Ayrıca tedavi stratejileri ve tedavi seçenekleri tartışılmıştır.

🔖

Cite This Article

ÇITAK, E. Ç., OĞUZ, A. (2022). Clinical characteristics and treatment modalities of childhood hemangiomas. Gaziantep Tıp Dergisi, Cilt: 15 - Sayı: 1, 71–79. https://ajindex.com/articles/518999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. l.Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg, 1982
  2. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues), Adv Dermatol, 1997
  3. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics, 1976
  4. Bruckner AL, Frieden II Hemangiomas of infancy. J Am Acad Dermatol, 2003
  5. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg, 2000
  6. Gonzales-Crussi F, Reyes-Mugica M. Cellular hemangiomas ("hemangioendotheliomas") in infants: light microscopic, immunohistochemical, and ultrastructural observations. Am J Surg Pathol, 1991
  7. Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezekowitz RAB. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest, 1994
  8. Tan ST, Velickovic M, Ruger BM, Davis PF. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg, 2000
  9. Kraling BM, Razon MJ, Boon LM, Zurakowski D, Seachord C, Darveau RP, et al. E-selectin is present in proliferating endothelial cells in humans hemangiomas. Am J Pathol 1996
  10. lO.Isik FF, Rand RP, Gruss JS, Benjamin D, Alpers CE. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J Surg Res, 1996
  11. North PE, Waner M, Mlzeracki A, Mihm MC. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000
  12. ll-22. 12.North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol, 2001
  13. Arbiser JL. Angiogenesis and the skin: a primer. J Am Acad Dermatol, 1996
  14. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med, 1995
  15. Cohen MM. Vasculogenesis, angiogenesis, hemangiomas, and vascular malformations. Am J Med Genet, 2002
  16. Walter JW, Blei F, Anderson JL, Orlow SJ, Speer MC, Marchuk DA. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet, 1999
  17. Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesionsxlinical application of a new classification. J Pediatr Surg, 1983
  18. Drolet BA, Esterly NB, Frieden IX Hemangiomas in chil